Expand ALUR Menu
ALUR MENU

ALUR Latest Press Releases

-- March 12, 2025 --

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025 Business Wire 4:05 PM

-- March 4, 2025 --

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity Business Wire 4:05 PM

-- February 25, 2025 --

Allurion to Participate in Upcoming Investor Conferences Business Wire 4:05 PM

-- February 20, 2025 --

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline Business Wire 4:05 PM

-- February 19, 2025 --

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline Business Wire 9:03 AM

-- February 18, 2025 --

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity Business Wire 8:30 AM

-- February 13, 2025 --

Allurion Relaunches in France Business Wire 8:30 AM

-- January 24, 2025 --

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market Business Wire 9:30 AM

-- January 23, 2025 --

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program Business Wire 3:48 PM

-- January 21, 2025 --

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity Business Wire 8:30 AM

-- January 14, 2025 --

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024 Business Wire 9:18 AM

-- January 8, 2025 --

Allurion Announces Positive Topline Results From AUDACITY Trial Business Wire 8:00 AM

-- December 24, 2024 --

Allurion Technologies, Inc. Announces Reverse Stock Split Business Wire 7:00 AM

-- December 2, 2024 --

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance Business Wire 8:00 AM

-- November 25, 2024 --

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program Business Wire 8:00 AM

-- November 13, 2024 --

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update Business Wire 8:00 AM

-- November 4, 2024 --

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society's Annual Conference Business Wire 8:10 AM

-- October 30, 2024 --

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024 Business Wire 8:30 AM

-- October 23, 2024 --

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon Business Wire 8:00 AM